Abacus Medicine starts production in the Netherlands
New site will offer daily flexibility and provide a contingency solution
Abacus Medicine has completed its first production at a new site in Alkmaar in the Netherlands. The new site will support the company’s main production facility in Budapest, Hungary, and serve as a possible back-up.
“The addition of a second site will offer us a number of advantages. It introduces a new level of flexibility and efficiency in our production planning, while simultaneously lowering our operational risk substantially. Today, we have ticked off another key element in our plans for continued growth,” says CEO Flemming Wagner.
A hub for specialized productions
Initially, the new production site will primarily provide support, for example by producing non-urgent orders. This will free up resources at the main production site in Hungary and allow it to focus on the more pressing orders.
“The Dutch authorities have already inspected our site successfully and issued the required GDP and GMP licenses. Over the course of the coming months, we will hire additional staff and ramp up production levels gradually,“ says Arwin Geijtenbeek, General Manager at Abacus Medicine Netherlands.
Wir helfen gerne, also scheuen Sie sich bitte nicht, uns bei Fragen zu kontaktieren. Untenstehend finden Sie unsere Hauptniederlassungen, in denen unsere Mitarbeiter aus ganz Europa arbeiten.
1620 Copenhagen V
Maglódi út 6
Berliner Straße 8
The Leadenhall Building,
122 Leadenhall Street,
London EC3V 4AB
12/14 Rond-Point des Champs-Elysées
Paris 75008, France